Eversept Partners, LP Portfolio Holdings

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

Eversept Partners, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.26 Billion distributed in 67 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Natera, Inc. with a value of $111M, Vera Therapeutics, Inc. with a value of $90.6M, Insmed Inc with a value of $79.5M, Syndax Pharmaceuticals Inc with a value of $79M, and Teva Pharmaceutical Industries LTD with a value of $58.3M.

Examining the 13F form we can see an decrease of $60.1M in the current position value, from $1.32B to 1.26B.

Eversept Partners, LP is based out at New York, NY

Below you can find more details about Eversept Partners, LP portfolio as well as his latest detailed transactions.

Portfolio value $1.26 Billion
Healthcare: $1.1 Billion
ETFs: $156 Million
Basic Materials: $4.35 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 67
  • Current Value $1.26 Billion
  • Prior Value $1.32 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 10 stocks
  • Additional Purchases 22 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 31 stocks
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email